| P2093 | author name string | Petersen J | |
| | Dandri M | |
| | Lütgehetmann M | |
| | Volz TK | |
| P2860 | cites work | Hepadnavirus infection in captive gibbons | Q24524742 |
| | RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement | Q28594711 |
| | Human hepatitis B virus and hepatocellular carcinoma I. Experimental infection of tree shrews with hepatitis B virus | Q29301931 |
| | Hepatitis C virus replication in mice with chimeric human livers | Q29620650 |
| | Double-stranded linear duck hepatitis B virus (DHBV) stably integrates at a higher frequency than wild-type DHBV in LMH chicken hepatoma cells. | Q33641725 |
| | Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration | Q43797431 |
| | Calcium signaling by HBx protein in hepatitis B virus DNA replication | Q43822550 |
| | Human hepatocytes transplanted into genetically immunocompetent rats are susceptible to infection by hepatitis B virus in situ | Q44201425 |
| | Cloned HBV DNA causes hepatitis in chimpanzees | Q44284928 |
| | Lamivudine therapy of WHV-infected woodchucks. | Q44610905 |
| | Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection | Q44698606 |
| | Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA. | Q44891407 |
| | Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes | Q45209563 |
| | Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene | Q45212760 |
| | Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes. | Q45522584 |
| | Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection | Q45732782 |
| | Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus | Q45737926 |
| | Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans | Q45742682 |
| | Full-genome sequence analyses of hepatitis B virus (HBV) strains recovered from chimpanzees infected in the wild: implications for an origin of HBV. | Q45744887 |
| | Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus | Q45747606 |
| | Hepatitis B virus transgenic mouse model of chronic liver disease | Q45748109 |
| | The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. | Q45751631 |
| | Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene | Q45770734 |
| | Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1. | Q45771260 |
| | Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes | Q45771892 |
| | In vitro experimental infection of primary human hepatocytes with hepatitis B virus | Q45779449 |
| | Woodchuck hepatitis virus: experimental infection and natural occurrence | Q45795929 |
| | HBx gene of hepatitis B virus induces liver cancer in transgenic mice | Q45852802 |
| | Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. | Q45876212 |
| | Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. | Q52530684 |
| | Properties of recombinant hepatitis B vaccine. | Q52848921 |
| | Transmission of Type B Viral Hepatitis to Chimpanzees | Q52852890 |
| | Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen | Q56950952 |
| | Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection | Q56951258 |
| | Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses | Q58811133 |
| | Replacement of diseased mouse liver by hepatic cell transplantation | Q72243460 |
| | Hepatitis B viruses and cancerogenesis | Q77356985 |
| | Mechanisms of cell engraftment during liver repopulation with hepatocyte transplantation | Q33647650 |
| | Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo. | Q33698569 |
| | Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections | Q33793723 |
| | Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus | Q33851722 |
| | Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. | Q33851759 |
| | In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir | Q33978910 |
| | Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks | Q33983079 |
| | Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro | Q34105204 |
| | Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus | Q34288062 |
| | Hepatitis B viruses and hepatocellular carcinoma | Q35232789 |
| | High-level hepatitis B virus replication in transgenic mice | Q35847850 |
| | The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice | Q35870718 |
| | Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection | Q35929219 |
| | Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis | Q36362505 |
| | Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways | Q36628106 |
| | Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences | Q36913034 |
| | Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. | Q36936499 |
| | MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. | Q37370581 |
| | Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner | Q37423197 |
| | Functional inactivation but not structural mutation of p53 causes liver cancer. | Q38300638 |
| | Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus | Q38461746 |
| | A new avian hepadnavirus infecting snow geese (Anser caerulescens) produces a significant fraction of virions containing single-stranded DNA. | Q39118763 |
| | The replication cycle of hepatitis B viruses | Q39199077 |
| | Envelope protein-mediated down-regulation of hepatitis B virus receptor in infected hepatocytes | Q39554543 |
| | T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge. | Q39582588 |
| | Loss and acquisition of duck hepatitis B virus integrations in lineages of LMH-D2 chicken hepatoma cells. | Q39873876 |
| | Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity | Q40046553 |
| | Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome | Q40130886 |
| | Virion DNA of ground squirrel hepatitis virus: structural analysis and molecular cloning | Q40142604 |
| | HBV and HDV replication in experimental models: effect of interferon | Q40394938 |
| | Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse. | Q40780186 |
| | Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes | Q40839917 |
| | Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection | Q40852082 |
| | A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice | Q40909623 |
| | The woodchuck: an animal model for hepatitis B virus infection in man. | Q41006688 |
| | Protection against hepatitis B virus infection by immunization with hepatitis B core antigen | Q41389342 |
| | A transgenic mouse model of the chronic hepatitis B surface antigen carrier state | Q41483768 |
| | Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses. | Q41722860 |
| | Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice | Q41736950 |
| | Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine). | Q41926048 |
| | Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees | Q43481833 |
| | Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation | Q43755036 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | S54-62 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | Journal of Clinical Virology | Q15759726 |
| P1476 | title | Animal models for the study of HBV replication and its variants | |
| P478 | volume | 34 Suppl 1 | |